These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3245249)

  • 1. [Status and perspectives of prevention in coronary heart disease].
    Knappe J; Heinemann L; Holtz H
    Z Gesamte Inn Med; 1988 Dec; 43(23):674-6. PubMed ID: 3245249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of ischemic heart disease--experiences and conclusions from the Erfurt intervention study].
    Knappe J
    Z Gesamte Inn Med; 1987 Oct; 42(19):536-9. PubMed ID: 3424884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The change of attitude of Hungarian physicians towards the importance of risk factors of coronary heart disease over the period 1985-1996.
    Márk L; Nagy E; Kondacs A; Deli L
    Public Health; 1998 May; 112(3):197-201. PubMed ID: 9629028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary coronary heart disease prevention in general practice. How does one recognize and define a risk patient?].
    Schwandt P
    MMW Fortschr Med; 1999 Oct; 141(43):26-8. PubMed ID: 10912117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperlipidemia as a risk factor for coronary heart disease among elderly people].
    Janocha J
    Przegl Lek; 2001; 58(9):855-8. PubMed ID: 11868247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European and American recommendations for coronary heart disease prevention.
    Wood D
    Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-Waluś B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Roman coronary heart disease prevention program. Final results].
    G Ital Cardiol; 1982; 12(8):541-54. PubMed ID: 7169153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of risk factors and risk behaviors related to coronary heart disease among blue and white collar males.
    Nourjah P; Wagener DK; Eberhardt M; Horowitz AM
    J Public Health Policy; 1994; 15(4):443-59. PubMed ID: 7883945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomized trial in primary care.
    Murchie P; Campbell NC; Ritchie LD; Deans HG; Thain J
    Fam Pract; 2004 Oct; 21(5):567-74. PubMed ID: 15367480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge of coronary heart disease risk factors among students of Warsaw universities].
    Olszewski R; Nowak A; Adamus J
    Pol Merkur Lekarski; 2002 Dec; 13(78):487-9. PubMed ID: 12666448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comprehensive population-effective control of ischemic heart disease and other chronic noncommunicable diseases in East Germany].
    Heine H; Heinemann L; Eckstein M; Hellmund W
    Cor Vasa; 1985; 27(5):325-8. PubMed ID: 4075797
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [20 years of cardiovascular epidemiology. The epidemiologist's viewpoint].
    Kornitzer M
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):563-76. PubMed ID: 9005492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opinion of the Polish scientific community concerning selected problems in the prevention of coronary disease. I. The theoretical premises of primary prevention].
    Piwoński J; Rywik S
    Kardiol Pol; 1981; 24(11-12):789-97. PubMed ID: 7341834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.